DVT After Cardiac Procedure
Is Deep Vein Thrombosis an Under-recognised Complication of Electrophysiology Procedures? A Mechanistic Observational Study Investigating Markers and Incidence of Thromboembolism
1 other identifier
observational
82
1 country
5
Brief Summary
Patients undergoing electrophysiology studies (EPS) and cardiac ablation procedure for the treatment of cardiac arrhythmias may be at increased risk of deep vein thrombosis (DVT) during or after the procedure, which may lead to pulmonary embolus which can be life threatening. The study will use Doppler ultrasound scanning at 24h and between 10-14 days post EPS and cardiac ablation to assess the incidence of undiagnosed DVT. A positive finding may provide support for a larger clinical trial to assess the benefit of prophylactic anticoagulation post EPS procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2017
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 20, 2017
CompletedFirst Submitted
Initial submission to the registry
February 15, 2019
CompletedFirst Posted
Study publicly available on registry
March 18, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2019
CompletedFebruary 5, 2025
February 1, 2025
1.8 years
February 15, 2019
February 3, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Presence of DVT as evidenced by Doppler Ultrasound
The incidence of DVT in the treated leg will be reported. The study will use Doppler ultrasound scanning post EPS and cardiac ablation to assess the incidence of undiagnosed DVT at up to 14 days post procedure.
Up to 14 days post procedure.
Secondary Outcomes (3)
Elevation of blood markers of DVT in the absence of clinically detectable DVT.
Blood sampling takes place pre-ablation and 24 hours post procedure.
Ultrasound characteristics of the DVT, and change between scans.
Up to 14 days post procedure.
The occurrence of DVT in the untreated leg.
Up to 14 days post procedure.
Eligibility Criteria
Patients referred for elective EP study and catheter ablation.
You may qualify if:
- Patients aged 18 - 80 undergoing elective EP study and catheter ablation
- Procedure duration between 30 minutes - 4 hours from the time of venous puncture to sheath removal
- sheaths in a femoral vein
You may not qualify if:
- Under 18
- Electrophysiology study only (no ablation performed)
- Inadequate understanding of spoken English
- Intubated/ventilated patients
- Unwilling to give consent to participation OR advised by consultee that this would be against the patient's wishes.
- Recently treated infection
- Intravascular implanted cardiac device
- Prior pacemaker extraction
- Prior cardiac surgery
- Previous cardiac ablation within 6 months
- Documented atrial flutter or atrial fibrillation within 1 year prior to ablation procedure.
- Participation in a clinical trial of an investigational medicinal product (CTIMP)
- Documented previous venous thrombosis or pulmonary embolism
- Known coagulopathy or anticoagulant use
- Known use of anti-platelet agent
- +6 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Manchester University NHS Foundation Trustlead
- Bristol-Myers Squibbcollaborator
Study Sites (5)
Blackpool Teaching Hospitals NHS Foundation Trust
Blackpool, Lancashire, United Kingdom
Nottingham University Hospitals NHS Trust
Nottingham, Nottinghamshire, United Kingdom
Sheffield Teaching Hospitals NHS Foundation Trust
Sheffield, Yorkshire, United Kingdom
Guy's and St Thomas' NHS Foundation Trust
London, United Kingdom
Manchester University NHS Foundation Trust
Manchester, M13 9WU, United Kingdom
Related Publications (1)
Bruce C, Saraf K, Rogers S, El-Omar M, Kirkwood G, Kelland NF, Shah D, Chalil S, Fullwood C, Wright M, Jamil-Copley S, Fox D, Abozguia K, Thachil J, McCollum C, Morris GM. Deep Vein Thrombosis is Common After Cardiac Ablation and Pre-Procedural D-Dimer Could Predict Risk. Heart Lung Circ. 2022 Jul;31(7):1015-1022. doi: 10.1016/j.hlc.2022.01.014. Epub 2022 Mar 14.
PMID: 35301985DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 15, 2019
First Posted
March 18, 2019
Study Start
October 20, 2017
Primary Completion
July 31, 2019
Study Completion
July 31, 2019
Last Updated
February 5, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share